C vs ITRM · P/E 16, rev $85.22B vs rev $390.0K
Citigroup Inc. (C) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
C currently screens at market cap $214.73B and trailing P/E 15.5. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the C and ITRM stock pages for the full models.
Not investment advice.